These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6865778)

  • 1. Carnitine and carnitine esters in plasma and adipose tissue of chronic uremic patients undergoing hemodialysis.
    Penn D; Schmidt-Sommerfeld E
    Metabolism; 1983 Aug; 32(8):806-9. PubMed ID: 6865778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carnitine and carnitine esters in acute renal failure.
    Wanner C; Riegel W; Schaefer RM; Hörl WH
    Nephrol Dial Transplant; 1989; 4(11):951-6. PubMed ID: 2516886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human forearm arteriovenous differences of carnitine, short-chain acylcarnitine and long-chain acylcarnitine.
    Bartlett K; Bhuiyan AK; Aynsley-Green A; Butler PC; Alberti KG
    Clin Sci (Lond); 1989 Oct; 77(4):413-6. PubMed ID: 2805599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketogenic and antiketogenic effects of L-carnitine in hemodialysis patients.
    Wanner C; Wieland H; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1989 Nov; 27():S264-8. PubMed ID: 2636668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy.
    Bertoli M; Battistella PA; Vergani L; Naso A; Gasparotto ML; Romagnoli GF; Angelini C
    Am J Clin Nutr; 1981 Aug; 34(8):1496-500. PubMed ID: 7270472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and red blood cell carnitine and carnitine esters during L-carnitine therapy in hemodialysis patients.
    Wanner C; Wäckerle B; Boeckle H; Schollmeyer P; Hörl WH
    Am J Clin Nutr; 1990 Mar; 51(3):407-10. PubMed ID: 2309647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
    Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
    Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of carnitine in patients with renal insufficiency.
    Wanner C; Hörl WH
    Klin Wochenschr; 1986 Jul; 64(13):579-86. PubMed ID: 3091903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis.
    Wanner C; Förstner-Wanner S; Schaeffer G; Schollmeyer P; Hörl WH
    Am J Nephrol; 1986; 6(3):206-11. PubMed ID: 3740128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a positive association between serum carnitine and free testosterone levels in uremic men with hemodialysis.
    Sakai K; Fukami K; Yamagishi S; Kaida Y; Adachi T; Ando R; Manabe R; Otsuka A; Sugi K; Ueda S; Okuda S
    Rejuvenation Res; 2013 Jun; 16(3):200-5. PubMed ID: 23488553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced carnitine palmitoyl transferase activity and altered acyl-trafficking in red blood cells from hemodialysis patients.
    de los Reyes B; Perez-García R; Liras A; Arenas J
    Biochim Biophys Acta; 1996 Jan; 1315(1):37-9. PubMed ID: 8611644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine disposition before and during valproate therapy in patients with epilepsy.
    Riva R; Albani F; Gobbi G; Santucci M; Baruzzi A
    Epilepsia; 1993; 34(1):184-7. PubMed ID: 8422857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between plasma carnitine, muscle carnitine and glycogen levels in maintenance hemodialysis patients.
    Debska-Slizień ; Kawecka A; Wojnarowski K; Prajs J; Malgorzewicz S; Kunicka D; Zdrojewski Z; Walysiak-Szydłowska ; Lipiński J; Rutkowski B
    Int J Artif Organs; 2000 Feb; 23(2):90-6. PubMed ID: 10741803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine metabolism in normal-weight and obese human subjects during fasting.
    Hoppel CL; Genuth SM
    Am J Physiol; 1980 May; 238(5):E409-15. PubMed ID: 7377339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered carnitine metabolism in dialysis patients with reduced physical function may be due to dysfunctional fatty acid oxidation.
    Murphy WJ; Steiber A; Connery GC; Carder J; Spry L; Hoppel C
    Nephrol Dial Transplant; 2012 Jan; 27(1):304-10. PubMed ID: 21765185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carnitine depletion during chronic hemodialysis: effect of substitution on free carnitine plasma levels.
    Broquet PE; Von Moos C; Frei J; Gobelet C; Wauters JP
    Adv Exp Med Biol; 1987; 223():287-90. PubMed ID: 3447448
    [No Abstract]   [Full Text] [Related]  

  • 19. Whole body fat oxidation before and after carnitine supplementation in uremic patients on chronic haemodialysis.
    Lundholm K; Persson H; Wennberg A
    Clin Physiol; 1988 Aug; 8(4):417-26. PubMed ID: 3409653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
    Evans AM; Faull RJ; Nation RL; Prasad S; Elias T; Reuter SE; Fornasini G
    Kidney Int; 2004 Oct; 66(4):1527-34. PubMed ID: 15458447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.